Atossa Therapeutics Inc. (ATOS)
ATOS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.56
+7.17% on the day
Market cap
$25.5M
Nano cap
Revenue
No annual revenue filed since the period ending 2015-12-31
Net income
No annual revenue filed since the period ending 2015-12-31
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | ATOS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2012 |
| SEC CIK | 0001488039 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials
No annual revenue filed since the period ending 2015-12-31.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-12 |
| Latest annual report | 10-K | 2026-03-25 |
| Latest quarterly / interim | 10-Q | 2026-08-07 |
| Latest current report | 8-K | 2026-10-09 |
| Latest proxy | DEF 14A | 2026-03-30 |
Source: SEC EDGAR submissions feed, 641 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc. | $2.53 | -5.60% | $25.4M |
| CNTX | Context Therapeutics Inc. | $0.2750 | -9.84% | $25.3M |
| ABVC | ABVC BioPharma Inc. | $0.9790 | -0.08% | $26.1M |
| BYSI | BeyondSpring Inc. | $0.6067 | -1.43% | $24.9M |
| IMMP | Immutep Limited | $3.57 | -2.73% | $26.3M |
| SHPH | Shuttle Pharmaceuticals Holdings Inc. | $5.18 | -4.95% | $24.7M |
| QNTM | Quantum Biopharma Ltd. Class B Subordinate Voting Shares | $2.89 | +2.48% | $24.5M |
| PBM | Psyence Biomedical Ltd. Common Shares | $4.55 | -4.01% | $24.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier